Joint health: Evidence-Based Supplement Guide

Six of the 72 people in Avelor with a saved stack hold something taken for joints. This is the category with the largest mismatch between what sells and what works, and the mismatch runs in a single direction. The two best-evidenced interventions are free and effortful, and the two best-selling supplements are among the weakest-evidenced things in the guide. Exercise is first-line in every current guideline (PMID 31908149, 31278997, 37394226). A network meta-analysis of exercise modalities in knee osteoarthritis concluded that **aerobic exercise is likely the most beneficial** for pain, function, gait and quality of life, at moderate certainty (PMID 41093618). An earlier network meta-analysis found all five exercise types it examined improved symptoms (PMID 37346776). A useful negative sits alongside: adding manual therapy to exercise therapy gave short-term benefit and, at **high certainty**, no benefit over exercise alone in the long term (PMID 35881705). Weight is the other lever. A randomised trial of diet plus exercise in people with knee osteoarthritis and overweight reported a statistically significant but **small** difference in knee pain, whose clinical importance the authors called uncertain (PMID 36511925). A randomised trial of once-weekly semaglutide in people with obesity and knee osteoarthritis reported greater reductions in both weight and knee pain than placebo (PMID 39476339). That is a prescription medicine and a decision for a clinician, not something to seek out from this guide. Now the two things people actually buy. A systematic review and meta-analysis of dietary supplements for osteoarthritis found that **glucosamine and chondroitin were either ineffective or showed small and arguably clinically unimportant effects** (PMID 29018060). It found supplements as a group had no clinically important effects on pain or function at medium-term or long-term follow-up. A review of the combination reported an effect while noting limited study numbers and uneven trial quality (PMID 35024906). A 2025 safety and efficacy review was more favourable and supported continued use (PMID 40647198). The reviews disagree, which is itself the finding: this is not a settled positive, and a product sold on decades of familiarity is resting on evidence that keeps failing to converge. The rest is mixed and in places better than expected. An updated systematic review and meta-analysis reported that oral collagen relieved osteoarthritis symptoms, with improvements the authors described as both statistically and clinically noteworthy (PMID 39212129). A randomised trial of an undenatured type II preparation supports it (PMID 26822714). Curcumin's arthritis reviews report symptom and inflammation improvement while stating the trials are too few and too low in quality for firm conclusions (PMID 35935936, 27533649). Boswellia has a systematic review in osteoarthritis (PMID 32680575). Omega-3 in rheumatoid arthritis reduced triglycerides and tender joint count (PMID 38922552), and anti-inflammatory diets reduced rheumatoid arthritis pain in a meta-analysis that rated every included study at high risk of bias (PMID 34959772). Methylsulfonylmethane has one randomised trial in mild knee pain (PMID 37447322). European recommendations conclude there is moderate evidence for a small benefit from certain dietary components and that high-level evidence of clinically meaningful effects is missing (PMID 35654458).

1. **Start with exercise, and prefer aerobic exercise if you have knee osteoarthritis** (PMID 41093618, 31908149). 2. **If weight is a factor, treat it as one of the two real levers** (PMID 36511925, 39476339). 3. **Do not expect manual therapy to add anything long term** (PMID 35881705). 4. **Know that glucosamine and chondroitin are the least settled things you can buy here**, not the most established (PMID 29018060, 35024906, 40647198). 5. **Tell your clinician what you take before any planned surgery or if you take an anticoagulant.**

Where the research supports a timeframe, the diet and exercise trial measured knee pain over **eighteen months** (PMID 36511925). The supplement reviews report effects at short term and their absence at medium and long term, which is the timescale that matters for a chronic joint condition (PMID 29018060). The manual therapy finding is explicitly short-term benefit and long-term equivalence (PMID 35881705).

- **The strongest supplement effects in this category are short-term and disappear with longer follow-up** (PMID 29018060). For a condition measured in years, that is close to the whole story. - **The glucosamine and chondroitin reviews genuinely disagree** (PMID 29018060, 40647198). This guide reports the disagreement rather than choosing the review that suits a conclusion. - **Curcumin's arthritis reviews say outright that their own evidence base is too small and too low in quality for firm conclusions** (PMID 35935936, 27533649). - **Anti-inflammatory diet evidence in rheumatoid arthritis rated every included study at high risk of bias** (PMID 34959772). - **One randomised trial is not an evidence base**, which is the state of methylsulfonylmethane here (PMID 37447322). - **Guidelines themselves lack consensus on some supplement and adjunctive options** (PMID 37394226), so a reader finding conflicting advice is seeing the literature accurately.

- **Glucosamine carries a precautionary caution with warfarin and with diabetes medicines, and the same review says no significant interactions have actually been reported** (PMID 18756654). Both halves are in one paper and both belong here. Raise it with **the clinician who manages your anticoagulant**, because clotting control is measured rather than felt, and a precaution is a reason to check rather than a reason to be alarmed. - **The shellfish-allergy warning on glucosamine is more nuanced than the internet version.** A study of shrimp-allergic individuals found that products from the manufacturers tested did not contain clinically relevant levels of shrimp allergen (PMID 17083356). A clinical review still advises caution in shellfish allergy and asthma (PMID 18756654). Both are cited here because the honest position is that it depends on the product, and that is a question for **a pharmacist**. - **Anti-inflammatory painkillers are not a safe default just because they are familiar.** A systematic review and meta-analysis found gastrointestinal bleeding risk varies substantially between agents and that they should not be treated as a uniform class (PMID 40915652). If you take one regularly, review it with **a clinician or pharmacist**, particularly alongside an anticoagulant (PMID 33769581). - **Turmeric and curcumin carry a liver-injury signal**, covered in the inflammation guide. Raise daily or enhanced-absorption use with **a pharmacist or clinician**. - **A hot, swollen, or intensely painful single joint, joint pain with fever, or joint swelling after an injury needs urgent assessment by a doctor**, not a supplement. Infection and crystal arthritis both present this way. - **Rheumatoid arthritis is treated, not supplemented** (PMID 32585000). Anything added goes past **the clinician managing it**.

Resolving to an entity and being interaction-checkable are different things. The interaction catalogue keys on a collapsed name string rather than an entity id. Resolves **and** has a catalogue key, so it can be interaction-checked: - `avelor:sup:omega-3`, `avelor:sup:omega-3-fish-oil` Resolves but has **no catalogue key**, so it displays as recognised and is checked against nothing: - `avelor:sup:glucosamine-sulfate` - `avelor:sup:boswellia` - `avelor:sup:omega-3-fatty-acids` No supplement entity, and none is invented here: **chondroitin**, **collagen**, **methylsulfonylmethane**, **hyaluronic acid**, **turmeric** and **avocado-soybean unsaponifiables**. Glucosamine is the case to look at. It is the best-selling supplement in this category, it resolves to `avelor:sup:glucosamine-sulfate`, and it carries no catalogue key. It is also the one item here with a named interaction caution involving an anticoagulant. So a user saving glucosamine sees a recognised ingredient and is matched against nothing, including against the warfarin caution this guide spends a bullet on. Chondroitin has no entity at all, which means the product cannot represent the other half of the combination most of these users are actually taking. And collagen, the item with the most favourable recent meta-analysis in this guide, cannot be represented either.

| PMID | Title | | --- | --- | | 31908149 | "2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee" | | 31278997 | "OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis" | | 37394226 | "Recommendations for the management of hip and knee osteoarthritis: A systematic review of clinical practice guidelines" | | 41093618 | "Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis" | | 37346776 | "Exercise Therapy for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis" | | 35881705 | "The Benefits of Adding Manual Therapy to Exercise Therapy for Improving Pain and Function in Patients With Knee or Hip Osteoarthritis: A Systematic Review With Meta-analysis" | | 36511925 | "Effect of Diet and Exercise on Knee Pain in Patients With Osteoarthritis and Overweight or Obesity: A Randomized Clinical Trial" | | 39476339 | "Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis" | | 29018060 | "Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis" | | 35024906 | "Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis" | | 40647198 | "The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review" | | 39212129 | "Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trials" | | 26822714 | "Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study" | | 35935936 | "Efficacy and Safety of Curcumin and" | | 27533649 | "Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials" | | 32680575 | "Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis" | | 38922552 | "Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials" | | 34959772 | "Effect of Anti-Inflammatory Diets on Pain in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis" | | 32585000 | "Rheumatoid arthritis and dietary interventions: systematic review of clinical trials" | | 37447322 | "Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial" | | 35654458 | "Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs" | | 18756654 | "Glucosamine" | | 17083356 | "Do shrimp-allergic individuals tolerate shrimp-derived glucosamine?" | | 40915652 | "Nonsteroidal Anti-Inflammatory Drugs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis" | | 33769581 | "Drug-drug interactions with warfarin: A systematic review and meta-analysis" |